Delivery Order SPE2DR25D1205-SPE2DR26F0YL3
Award Date 12/17/25
Potential Completion Date 1/9/26
Potential Value $9.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $46,511 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of LEQVIO 284 mg/1.5 mL syringes, with an ultimate completion date of September 25, 2025. This competitively awarded contract contains no set-aside designation and specifies performance at AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,325.55 to AmerisourceBergen Drug Corp for LEQVIO 284 mg/1.5 ml syringes on June 26, 2025, with an ultimate completion date of July 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,507.70 to AmerisourceBergen Drug Corp for the supply of LEQVIO 284 mg/1.5 mL syringes. The contract is a firm fixed price delivery order with an ultimate completion date of December 17, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $24.5K delivery order to AmerisourceBergen Drug Corp for supply of LEQVIO 284 mg/1.5 mL syringes. The contract is classified as firm fixed price with an ultimate completion date of January 9, 2026, and was awarded on December 17, 2025. This is a non-set-aside award issued as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a $23,255.50 delivery order to AmerisourceBergen Drug Corp for LEQVIO 284 mg/1.5 ml syringes on August 18, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and specifies performance at the contractor's location in Conshohocken, Pennsylvania. LEQVIO is an injectable cardiovascular medication used to lower LDL cholesterol levels, reflecting the Defense...
- The Defense Logistics Agency awarded a $9.3K delivery order to AmerisourceBergen Drug Corp for LEQVIO 284 mg/1.5 ml syringes on September 26, 2025, with completion targeted for October 20, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. LEQVIO is a prescription medication used to lower cholesterol levels, and this delivery order represents a discrete...
- The Defense Logistics Agency awarded a $23,255.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Leqvio 284 mg/1.5 ml syringes, with an ultimate completion date of December 3, 2025. This non-set-aside contract represents a competitive award for pharmaceutical procurement supporting federal medical supply needs. The delivery order is classified as a child contract, indicating it derives from a larger vehicle agreement—specifically AmerisourceBergen's Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of LEQVIO 284 mg/1.5 mL syringes with a ceiling value of $49,015.40. This is a firm fixed-price delivery order with an ultimate completion date of January 9, 2026, representing a pediatric/medical supply for pharmaceutical distribution. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in...
- The Defense Logistics Agency awarded a $13,953.30 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of LEQVIO 284 mg/1.5 mL syringes. The contract, which is non-set-aside and competitively awarded, carries an ultimate completion date of September 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of LEQVIO 284 mg/1.5 ml syringes with a contract ceiling value of $7,352.31. This firm fixed-price delivery order, which is not set-aside and carries an ultimate completion date of December 5, 2025, represents a competitively awarded procurement. The product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...